CC chemokine ligand 3 overcomes the bacteriocidal and phagocytic defect of macrophages and hastens recovery from experimental otitis media in TNF -/- mice

Journal of Immunology

Volumn 184, Issue 6, 2010, Pages 3087-3097

  Leichtle, Anke ^a,d   Hernandez, Michelle ^b,f   Ebmeyer, Joerg ^e   Yamasaki, Kenshi ^c   Lai, Yuping ^c   Radek, Katherine ^c   Choung, Yun Hoon ^a,g   Euteneuer, Sara ^d   Pak, Kwang ^a   Gallo, Richard ^c   Wasserman, Stephen I ^b   Ryan, Allen F ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF LÜBECK   (Germany)

^e Klinikum Bielefeld   (Germany)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RECOMBINANT TUMOR NECROSIS FACTOR; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; AUTACOID; CCL3 PROTEIN, MOUSE; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE; IN VITRO SELECTION; IN VIVO STUDY; INFLAMMATORY CELL; INNATE IMMUNITY; MOUSE; NONHUMAN; OTITIS MEDIA; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; UPREGULATION; WILD TYPE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DISEASE MODEL; DOWN REGULATION; GENETICS; HAEMOPHILUS INFECTION; IMMUNOLOGY; MICROBIOLOGY; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SERUM BACTERICIDAL ACTIVITY;

ANIMALS; BLOOD BACTERICIDAL ACTIVITY; CHEMOKINE CCL3; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; INFLAMMATION MEDIATORS; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OTITIS MEDIA; PHAGOCYTOSIS; RECOMBINANT PROTEINS; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77951905332     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901167     Document Type: Article

References (52)

1. World Health Organization-Prevention of Deafness and Hearing Impairment. 1996. Workmen's Compensation Fund Workshop. D. Prevention of hearing impairment from chronic otitis media. WHO/PDH/98.4. London.
2. CIiBA Foundation 19-11-1996, S. Couzos, R. Murray, and National Aboriginal Community Controlled Health Organisation (NACCHO). 2001. Systematic Review of Existing Evidence and Primary Care Guidelines on the Management of Otitis Media in Aboriginal and Torres Strait Islander Populations. Office for Aboriginal and Torres Strait Islander Health, Canberra, Australia.
3. World Health Organization. 1993. World Health Organization World Development Report 1993: Investing in Health. Oxford University Press, Oxford, p. 215-222.
4. Infante-Rivard, C., and A. Fernández. 1993. Otitis media in children: frequency, risk factors, and research avenues. Epidemiol. Rev. 15: 444-465.
5. Del Mar, C., P. Glasziou, and M. Hayem. 1997. Are antibiotics indicated as initial treatment for children with acute otitis media? A meta-analysis. BMJ 314: 1526-1529. (Pubitemid 27216070)
6. Klein, J. O. 2000. The burden of otitis media. Vaccine 19(Suppl 1): S2-S8.
7. Maw, R., J. Wilks, I. Harvey, T. J. Peters, and J. Golding. 1999. Early surgery compared with watchful waiting for glue ear and effect on language development in preschool children: a randomised trial. Lancet 353: 960-963. (Pubitemid 29132604)
8. Bennett, K. E., M. P. Haggard, P. A. Silva, and I. A. Stewart. 2001. Behaviour and developmental effects of otitis media with effusion into the teens. Arch. Dis. Child. 85: 91-95.
9. Hernandez,M., A.Leichtle, K. Pak, J.Ebmeyer, S. Euteneuer,M.Obonyo,D.G. Guiney, N. J. Webster, D. H. Broide, A. F. Ryan, and S. I. Wasserman. 2008. Myeloid differentiation primary response gene 88 is required for the resolution of otitis media. J. Infect. Dis. 198: 1862-1869.
10. Leichtle, A., M. Hernandez, K. Pak, K. Yamasaki, C. F. Cheng, N. J. Webster, A. F. Ryan, and S. I. Wasserman. 2009. TLR4-mediated induction of TLR2 signaling is critical in the pathogenesis and resolution of otitis media. Innate Immun. 15: 205-215.
11. Emonts, M., R. H. Veenhoven, S. P. Wiertsema, J. J. Houwing-Duistermaat, V. Walraven, R. de Groot, P. W. Hermans, and E. A. Sanders. 2007. Genetic polymorphisms in immunoresponse genes TNFA, IL6, IL10, and TLR4 are associated with recurrent acute otitis media. Pediatrics 120: 814-823. (Pubitemid 47549570)
12. Wiertsema, S. P., S. K. Khoo, G. Baynam, R. H. Veenhoven, I. A. Laing, G. A. Zielhuis, G. T. Rijkers, J. Goldblatt, P. N. Lesouëf, and E. A. Sanders. 2006. Association of CD14 promoter polymorphism with otitis media and pneumococcal vaccine responses. Clin. Vaccine Immunol. 13: 892-897.
13. Emonts, M., R. H. Veenhoven, S. P. Wiertsema, J. J. Houwing-Duistermaat, V. Walraven, R. de Groot, P. W. Hermans, and E. A. Sanders. 2007. Genetic polymorphisms in immunoresponse genes TNFA, IL6, IL10, and TLR4 are associated with recurrent acute otitis media. Pediatrics 120: 814-823.
14. Leibovitz, E., E. Asher, L. Piglansky, N. Givon-Lavi, R. Satran, S. Raiz, Y. Slovik, A. Leiberman, and R. Dagan. 2007. Is bilateral acute otitis media clinically different than unilateral acute otitis media? Pediatr. Infect. Dis. J. 26: 589-592.
15. Eldika, N., and S. Sethi. 2006. Role of nontypeable Haemophilus influenzae in exacerbations and progression of chronic obstructive pulmonary disease. Curr. Opin. Pulm. Med. 12: 118-124.
16. Karalus, R. J., and T. F. Murphy. 1999. Purification and characterization of outer membrane protein P6, a vaccine antigen of non-typeable Haemophilus influenzae. FEMS Immunol. Med. Microbiol. 26: 159-166.
17. Barenkamp, S. J. 1992. Outer membrane proteins and lipopolysaccharides of nontypeable Haemophilus influenzae. J. Infect. Dis. 165(Suppl 1): S181-S184.
18. Shuto, T., H. Xu, B. Wang, J. Han, H. Kai, X. X. Gu, T. F. Murphy, D. J. Lim, and J. D. Li. 2001. Activation of NF-κB by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKKα/β-IκBα and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 98: 8774-8779.
19. DiDonato, J. A., M. Hayakawa, D. M. Rothwarf, E. Zandi, and M. Karin. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388: 548-554.
20. Karin, M. 1999. How NF-κB is activated: the role of the IκB kinase (IKK) complex. Oncogene 18: 6867-6874.
21. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21: 335-376.
22. Medzhitov, R., and C. Janeway, Jr. 2000. Innate immune recognition: mechanisms and pathways. Immunol. Rev. 173: 89-97.
23. Bradley, J. R. 2008. TNF-mediated inflammatory disease. J. Pathol. 214: 149-160.
24. Catanzaro, A., A. Ryan, S. Batcher, and S. I. Wasserman. 1991. The response to human rIL-1, rIL-2 and rTNF in the middle ear of guinea pigs. Laryngoscope 101: 271-275.
25. Jeon, E. J., Y. S. Park, Y. C. Choi, S. W. Yeo, and T. T. Jung. 2001. Effect of inhibitor of tumor necrosis factor-α on experimental otitis media with effusion. Ann. Otol. Rhinol. Laryngol. 110: 917-921.
26. Lee, D. H., Y. S. Park, T. T. Jung, S. W. Yeo, Y. C. Choi, and E. Jeon. 2001. Effect of tumor necrosis factor-α on experimental otitis media with effusion. Laryngoscope 111: 728-733. (Pubitemid 32295292)
27. Kim, D. H., Y. S. Park, E. J. Jeon, S. W. Yeo, K. H. Chang, and S. K. Lee. 2006. Effects of tumor necrosis factor α antagonist, platelet activating factor antagonist, and nitric oxide synthase inhibitor on experimental otitis media with effusion. Ann. Otol. Rhinol. Laryngol. 115: 617-623.
28. Park, Y. S., H. J. Auo, E. J. Jeon, K. H. Chang, S. K. Lee, and D. H. Lee. 2006. Effect of inhibitor of tumor necrosis factor-α and oxatomide on immune mediated otitis media. Laryngoscope 116: 1642-1646.
29. Patel, J. A., S. Nair, K. Revai, J. Grady, K. Saeed, R. Matalon, S. Block, and T. Chonmaitree. 2006. Association of proinflammatory cytokine gene polymorphisms with susceptibility to otitis media. Pediatrics 118: 2273-2279. (Pubitemid 46397564)
30. Alper, C. M., B. Winther, J. O. Hendley, and W. J. Doyle. 2009. Cytokine polymorphisms predict the frequency of otitis media as a complication of rhinovirus and RSV infections in children. Eur. Arch. Otorhinolaryngol. 266: 199-205.
31. Jono, H., J. H. Lim, L. F. Chen, H. Xu, E. Trompouki, Z. K. Pan, G. Mosialos, and J. D. Li. 2004. NF-κB is essential for induction of CYLD, the negative regulator of NF-κB: evidence for a novel inducible autoregulatory feedback pathway. J. Biol. Chem. 279: 36171-36174.
32. Takahashi, H., T. Tashiro, M. Miyazaki, M. Kobayashi, R. B. Pollard, and F. Suzuki. 2002. An essential role of macrophage inflammatory protein 1α/CCL3 on the expression of host's innate immunities against infectious complications. J. Leukoc. Biol. 72: 1190-1197.
33. Montecucco, F., S. Steffens, F. Burger, A. Da Costa, G. Bianchi, M. Bertolotto, F. Mach, F. Dallegri, and L. Ottonello. 2008. Tumor necrosis factor-alpha (TNF-α) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1α) on human neutrophils through defined signalling pathways. Cell. Signal. 20: 557-568.
34. Ottonello, L., F. Montecucco, M. Bertolotto, N. Arduino, M. Mancini, A. Corcione, V. Pistoia, and F. Dallegri. 2005. CCL3 (MIP-1α) induces in vitro migration of GM-CSF-primed human neutrophils via CCR5-dependent activation of ERK 1/2. Cell. Signal. 17: 355-363.
35. Broxmeyer, H. E., B. Sherry, L. Lu, S. Cooper, C. Carow, S. D. Wolpe, and A. Cerami. 1989. Myelopoietic enhancing effects of murine macrophage inflammatory proteins 1 and 2 on colony formation in vitro by murine and human bone marrow granulocyte/macrophage progenitor cells. J. Exp. Med. 170: 1583-1594.
36. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of gramnegative and gram-positive bacterial cell wall components. Immunity 11: 443-451. (Pubitemid 29504199)
37. Melhus, A., and A. F. Ryan. 2003. A mouse model for acute otitis media. APMIS 111: 989-994. (Pubitemid 37352619)
38. Schauber, J., R. A. Dorschner, A. B. Coda, A. S. Büchau, P. T. Liu, D. Kiken, Y. R. Helfrich, S. Kang, H. Z. Elalieh, A. Steinmeyer, et al. 2007. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Invest. 117: 803-811.
39. Blander, J. M., and R. Medzhitov. 2004. Regulation of phagosome maturation by signals from toll-like receptors. Science 304: 1014-1018.
40. Laroux, F. S., X. Romero, L. Wetzler, P. Engel, and C. Terhorst. 2005. Cutting edge: MyD88 controls phagocyte NADPH oxidase function and killing of gramnegative bacteria. J. Immunol. 175: 5596-5600.
41. Matsuguchi, T., T. Musikacharoen, T. Ogawa, and Y. Yoshikai. 2000. Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages. J. Immunol. 165: 5767-5772.
42. Verstrepen, L., T. Bekaert, T. L. Chau, J. Tavernier, A. Chariot, and R. Beyaert. 2008. TLR-4, IL-1R and TNF-R signaling to NF-κB: variations on a common theme. Cell. Mol. Life Sci. 65: 2964-2978.
43. Calandra, T., J. Bernhagen, R. A. Mitchell, and R. Bucala. 1994. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179: 1895-1902.
44. Xu, Y., N. H. Hunt, and S. Bao. 2007. The correlation between proinflammatory cytokines, MAdCAM-1 and cellular infiltration in the inflamed colon from TNF-α gene knockout mice. Immunol. Cell Biol. 85: 633-639.
45. Botha, T., and B. Ryffel. 2003. Reactivation of latent tuberculosis infection in TNF-deficient mice. J. Immunol. 171: 3110-3118. (Pubitemid 37093534)
46. Ramos, C. D., C. Canetti, J. T. Souto, J. S. Silva, C. M. Hogaboam, S. H. Ferreira, and F. Q. Cunha. 2005. MIP-1α[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-α and LTB4. J. Leukoc. Biol. 78: 167-177.
47. Xue, M. L., A. Thakur, N. Cole, A. Lloyd, F. Stapleton, D. Wakefield, and M. D. Willcox. 2007. A critical role for CCL2 and CCL3 chemokines in the regulation of polymorphonuclear neutrophils recruitment during corneal infection in mice. Immunol. Cell Biol. 85: 525-531.
48. Hachicha, M., P. H. Naccache, and S. R. McColl. 1995. Inflammatory microcrystals differentially regulate the secretion of macrophage inflammatory protein 1 and interleukin 8 by human neutrophils: a possible mechanism of neutrophil recruitment to sites of inflammation in synovitis. J. Exp. Med. 182: 2019-2025.
49. Lindell, D. M., T. J. Standiford, P. Mancuso, Z. J. Leshen, and G. B. Huffnagle. 2001. Macrophage inflammatory protein 1α/CCL3 is required for clearance of an acute Klebsiella pneumoniae pulmonary infection. Infect. Immun. 69: 6364-6369.
50. Ku, C.-L., H. von Bernuth, C. Picard, S. Y. Zhang, H. H. Chang, K. Yang, M. Chrabieh, A. C. Issekutz, C. K. Cunningham, J. Gallin, et al. 2007. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J. Exp. Med. 204: 2407-2422.
51. von Bernuth, H., C. Picard, Z. Jin, R. Pankla, H. Xiao, C. L. Ku, M. Chrabieh, I. B. Mustapha, P. Ghandil, Y. Camcioglu, et al. 2008. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321: 691-696.
52. Orange, J. S., A. Jain, Z. K. Ballas, L. C. Schneider, R. S. Geha, and F. A. Bonilla. 2004. The presentation and natural history of immunodeficiency caused by nuclear factor κB essential modulator mutation. J. Allergy Clin. Immunol. 113: 725-733.